Exfoliative dermatitis
☆ Muzotsatira za 2022 Stiftung Warentest zochokera ku Germany, kukhutitsidwa kwa ogula ndi ModelDerm kunali kotsika pang'ono kusiyana ndi kuyankhulana kwa telemedicine komwe kulipiridwa.
Red (burning) Skin Syndrome ― Erythema ndi sikelo pa thupi lonse ndizizindikiro zazikulu za Exfoliative dermatitis.
References
Erythroderma ndizovuta koma zowopsa. Ngakhale kuti chomwe chimayambitsa nthawi zambiri sichidziwika, chikhoza kuyambitsidwa ndi mankhwala osokoneza bongo kapena khansa. Khansara imodzi yodziwika bwino yolumikizidwa ndi dermatitis ya exfoliative ndi T-cell lymphoma ya cutaneous, yomwe imatha kusawonetsa zizindikiro kwa miyezi kapena zaka pambuyo poyambira khungu. Nthawi zambiri, kugonekedwa m'chipatala kumafunikira pakuwunika koyambirira ndi chithandizo. Odwala omwe ali ndi matenda oyambitsidwa ndi mankhwala nthawi zambiri amakhala ndi malingaliro abwino kwa nthawi yayitali, ngakhale milandu yopanda chifukwa chomveka imakhala ndi njira yobwereza komanso yobwereza. Kuneneratu kwa milandu yokhudzana ndi khansa nthawi zambiri kumadalira momwe khansara imakulira.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Nthawi zambiri amawonetsa kufiyira komanso kuphulika komwe kumaphimba 90% ya thupi. Matendawa ndi chizindikiro chowonekera chazovuta zosiyanasiyana zaumoyo monga psoriasis, eczema, kapena kuyankha kwamankhwala ena.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
Choyambitsa chachikulu cha erythroderma ndi kuwonjezereka kwa matenda a khungu, monga psoriasis, contact dermatitis, seborrheic dermatitis, lichen planus, pityriasis rubra pilaris kapena mankhwala osokoneza bongo, monga kugwiritsa ntchito topical steroids. Kuwongolera koyambirira sikumachitika kawirikawiri ndipo nthawi zambiri kumawonekera pakhungu la T-cell lymphoma. Chifukwa ndikofunika kusiyanitsa ndi T cell lymphoma ya cutaneous, biopsy imachitidwa.